Results from a mid-stage trial showed treatment with Genentech Inc's Avastin improved survival for patients with recurring brain cancer, the company said on Thursday.
Thallion Pharmaceuticals has received authorization from the Therapeutic Products Directorate of Health Canada to begin a Phase II clinical trial evaluating TLN-4601 as a monotherapy treatment for patients with glioblastoma multiforme, an advanced form of brain cancer, as a second line therapy.
After a brand is discontinued, what’s left is a name and the memories in consumers’ minds. To make money, maybe those memories †real or imagined †are all you need.
Massachusetts Sen. Edward Kennedy remained in the hospital Sunday, awaiting test results that could explain why the 76-year-old Democrat suffered a seizure a day earlier.
Doctors were working Sunday to determine the cause of a seizure that sent Sen. Ted Kennedy to the hospital and prompted an outpouring of support for the liberal political icon.
Doctors were working Sunday to determine the cause of a seizure that sent Sen. Edward M. Kennedy to the hospital and prompted an outpouring of support for the liberal political icon.
Synthetic Blood International, Inc. (OTCBB:SYBD) announced today that the company is currently fulfilling additional data requirements posed by the U.S. Food & Drug Administration (FDA) in connection with the protocol for its planned Phase II-b clinical trial of Oxycyte(R) in Traumatic Brain Injury (TBI) patients. The company expects to have the additional data submitted to the agency by the end
Doctors were working today to determine the cause of a seizure the sent Sen. Edward M. Kennedy to the hospital and prompted an outpouring of support for the liberal political icon.
Thallion Pharmaceuticals Inc. today announced it has received authorization from the Therapeutic Products Directorate of Health Canada to initiate a Phase II clinical trial evaluating TLN-4601 as a monotherapy treatment for patients with glioblastoma multiforme, an advanced form of brain cancer, as a second line therapy.